These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29044394)

  • 21. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation.
    Mortensen MB; Kulenovic I; Klausen IC; Falk E
    J Clin Lipidol; 2016; 10(5):1145-1152.e1. PubMed ID: 27678431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
    Nanchen D; Gencer B; Auer R; Räber L; Stefanini GG; Klingenberg R; Schmied CM; Cornuz J; Muller O; Vogt P; Jüni P; Matter CM; Windecker S; Lüscher TF; Mach F; Rodondi N
    Eur Heart J; 2015 Sep; 36(36):2438-45. PubMed ID: 26142466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia.
    Paquette M; Dufour R; Baass A
    J Clin Lipidol; 2017; 11(1):80-86. PubMed ID: 28391914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice.
    Troeung L; Arnold-Reed D; Chan She Ping-Delfos W; Watts GF; Pang J; Lugonja M; Bulsara M; Mortley D; James M; Brett T
    Heart; 2016 Jun; 102(11):855-61. PubMed ID: 26864669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the external validity of the SAFEHEART risk prediction model in patients with familial hypercholesterolaemia in an English routine care cohort.
    McKay AJ; Gunn LH; Ray KK
    Atherosclerosis; 2022 Oct; 358():68-74. PubMed ID: 35953355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials.
    Ellis KL; Pang J; Schultz CJ; Watts GF
    Eur J Prev Cardiol; 2017 Jul; 24(11):1200-1205. PubMed ID: 28482694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia.
    Paquette M; Chong M; Thériault S; Dufour R; Paré G; Baass A
    J Clin Lipidol; 2017; 11(3):725-732.e5. PubMed ID: 28456682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial Hypercholesterolaemia in the Era of Genetic Testing.
    Hughes DP; Viljoen A; Wierzbicki AS
    Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study.
    Schmidt N; Schmidt B; Dressel A; Gergei I; Klotsche J; Pieper L; Scharnagl H; Kleber ME; März W; Lehnert H; Pittrow D; Stalla G; Wittchen HU; Grammer TB
    Atherosclerosis; 2017 Nov; 266():24-30. PubMed ID: 28946037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors.
    Alonso R; Mata N; Castillo S; Fuentes F; Saenz P; Muñiz O; Galiana J; Figueras R; Diaz JL; Gomez-Enterría P; Mauri M; Piedecausa M; Irigoyen L; Aguado R; Mata P;
    Atherosclerosis; 2008 Oct; 200(2):315-21. PubMed ID: 18243212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia.
    Koeijvoets KC; van der Net JB; Dallinga-Thie GM; Steyerberg EW; Mensink RP; Kastelein JJ; Sijbrands EJ; Plat J
    Atherosclerosis; 2009 Jun; 204(2):453-8. PubMed ID: 18977479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular risk assessment of dyslipidemic children: analysis of biomarkers to identify monogenic dyslipidemia.
    Medeiros AM; Alves AC; Aguiar P; Bourbon M;
    J Lipid Res; 2014 May; 55(5):947-55. PubMed ID: 24627126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial hypercholesterolaemia: the Cape Town experience.
    Firth JC; Marais AD
    S Afr Med J; 2008 Feb; 98(2):99-104. PubMed ID: 18350202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia.
    Kastelein JJ; Ginsberg HN; Langslet G; Hovingh GK; Ceska R; Dufour R; Blom D; Civeira F; Krempf M; Lorenzato C; Zhao J; Pordy R; Baccara-Dinet MT; Gipe DA; Geiger MJ; Farnier M
    Eur Heart J; 2015 Nov; 36(43):2996-3003. PubMed ID: 26330422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study.
    Mundal L; Veierød MB; Halvorsen T; Holven KB; Ose L; Iversen PO; Tell GS; Leren TP; Retterstøl K
    Eur J Prev Cardiol; 2016 Dec; 23(18):1962-1969. PubMed ID: 27558979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
    Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ;
    Eur J Prev Cardiol; 2015 Jul; 22(7):849-54. PubMed ID: 24776375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease.
    Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I
    Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.